NEWS
Homeschooling for researchers-to-be
Corona lockdown has forced Ullern students to study from home via digital classes.
Research on gene-edited embryos allowed
Important cancer research into gene-editing human embryos will now be possible in Norway
New member: Adjutec Pharma
Meet our new member Adjutec Pharma, a company with new technology against multi-drug resistant bacteria.
Helsenæringens verdi 2020
Helsenæringen er en dobbel mulighet for Norge.
Norwegian cancer drug in COVID 19-programme
Bemcentinib from the Norwegian biotech BerGenBio will be tested on COVID-19 patients.
Artificial intelligence in the fight against COVID-19
Adapting cancer-fighting artificial intelligence technology to combat COVID-19.
Accelerating cell therapies against cancer
Oslo Cancer Cluster Incubator will develop the infrastructure for cancer cell therapies.
Programming to understand artificial intelligence
How can programming, artificial intelligence and machine learning help us to better understand the human brain?
New member: Glaxo Smith Kline
Find out how Glaxo Smith Kline (GSK), the latest pharmaceutical cluster to enter into our ecosystem, is contributing to the oncology field.
